ArticleCancer immunology, immunotherapy : CII2025

Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies.

Zhihao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.